DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ntskvb/contraception) has announced the addition of the "Contraception Partnering 2009-2014" report to their offering.
The Contraception Partnering 2009-2014 provides understanding and access to the contraception partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an analysis of contraception partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors contraception technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
This data driven report contains over 40 links to online copies of actual contraception deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
The initial chapters of this report provide an orientation of contraception partnering trends.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in contraception partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.
Chapter 3 provides an overview of the leading contraception deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive directory of contraception partnering deals signed and announced since 2009. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.
This data driven report includes:
- Trends in contraception dealmaking in the biopharma industry since 2009
- Access to summary headline, upfront, milestone and royalty data
- The leading contraception deals by value since 2009
In Contraception Partnering 2009-2014, the available deals are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Company A-Z
- Industry sector
- Stage of development at signing
- Deal component type
- Technology type
For more information visit http://www.researchandmarkets.com/research/ntskvb/contraception